FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104092 [Registered on: 17/02/2026] Trial Registered Prospectively
Last Modified On: 17/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Observational study of Clinical Characteristics and outcome of snakebite patients at a tertiary care center in Purvanchal, India 
Scientific Title of Study   Clinical profile and outcome of snake envenomation in patients presenting to tertiary care center of Purvanchal,India- An observational study. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vandana  
Designation  Junior resident 
Affiliation  IMS,BHU 
Address  Department of Anaesthesiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi
Department of Anaesthesiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi
Varanasi
UTTAR PRADESH
221005
India 
Phone  8987415191  
Fax    
Email  Vandanasingh39270@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vandana  
Designation  Junior resident 
Affiliation  IMS,BHU 
Address  Department of Anaesthesiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi
Department of Anaesthesiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi
Varanasi
UTTAR PRADESH
221005
India 
Phone  8987415191  
Fax    
Email  Vandanasingh39270@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vandana  
Designation  Junior resident 
Affiliation  IMS ,BHU 
Address  Department of Anaesthesiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi
Department of Anaesthesiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi
Varanasi
UTTAR PRADESH
221005
India 
Phone  8987415191  
Fax    
Email  Vandanasingh39270@gmail.com  
 
Source of Monetary or Material Support  
Nil. 
 
Primary Sponsor  
Name  Sir Sunderlal Hospital, IMS,BHU 
Address  IMS,BHU,Varanasi-221005 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kavita Meena  Sir Sunderlal Hospital   Department of Anaesthesiology, Institute of medical sciences, Banaras Hindu University
Varanasi
UTTAR PRADESH 
9711897587

kvtamn68@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Commitee,IMS,BHU  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: T630||Toxic effect of snake venom,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1)Confirmed or suspected history of snakebite.
2)Patients with clinical signs and symptoms of envenomation.
3)Admitted to emergency department and Intensive Care Unit.
4)Received or considered for anti-snake venom therapy  
 
ExclusionCriteria 
Details  1)Dry bites.
2)Age less than 18 years and more than 65years
3)Unknown bite source or cases.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess the clinical profile and outcomes of patients with snake envenomation admitted to tertiary care center of Purvanchal, India.  To assess the clinical profile and outcomes of patients presenting with snake envenomation from admission (baseline),1week,2week,3week, 4week further till discharge  
 
Secondary Outcome  
Outcome  TimePoints 
1)Determine demographic characteristics.
2)classify type of envenomation.
3)Evaluate complications associated with snake envenomation.
 
Assesing from admission(baseline) to 1week,2week,3week,4week further till discharge of participants. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   AIM: To assess clinical profile and outcome of snake envenomation in patients presenting to tertiary care center of Purvanchal,  India.
METHODS: Study will be conducted after ethics committee approval in patients presenting with  clinical signs and symptoms  of snakebite in emergency department and Intensive Care Unit. Clinical profile and treatment outcomes will be assessed in snake envenomation patients. 
PRIMARY OBJECTIVE:To assess clinical profile and outcomes of patients with snake envenomation.
SECONDARY OBJECTIVES:1)Determine demographic characteristics  of patients with snake bite 
2)Classify type of snake 
3)Identify time interval between bite and Hospital presentation. 


 
Close